Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
EKSO:NASDAQ
Ekso Bionics Holdings Inc
11,79 USD
-1,83%
(-0,22) 1D
11,96 USD
+1,44% (+0,17)
After hours
Closed: 1-май, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EKSO...
Open
12,26 USD
High
12,31 USD
Low
10,98 USD
Mkt. cap
42,01 млн
Avg. vol.
73,11 миң
Volume
47,62 миң
52-wk high
13,50 USD
52-wk low
2,75 USD
EPS
-4,91 USD
Beta
0,78
Shares outstanding
3,56 млн
No. of employees
50
News stories
From sources across the web
Profile
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
About Ekso Bionics Holdings Inc
CEOScott Davis
Employees50
Founded2005
HeadquartersСан Рафаел, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websiteeksobionics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
2,06 млн
4,23 млн
3,14 млн
2,14 млн
Cost of goods sold
1,24 млн
1,68 млн
1,47 млн
1,07 млн
Cost of revenue
1,24 млн
1,68 млн
1,47 млн
1,07 млн
Research and development expenses
852,00 миң
550,00 миң
31,00 миң
583,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,94 млн
3,40 млн
5,40 млн
6,11 млн
Operating expense
4,79 млн
3,95 млн
5,43 млн
6,69 млн
Total operating expenses
6,03 млн
5,63 млн
6,90 млн
7,76 млн
Operating income
-3,98 млн
-1,40 млн
-3,76 млн
-5,62 млн
Other non operating income
-8,00 миң
-5,00 миң
20,00 миң
-740,00 миң
EBT including unusual items
-2,71 млн
-1,42 млн
-4,67 млн
-6,88 млн
EBT excluding unusual items
-2,71 млн
-1,42 млн
-3,92 млн
-6,74 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,71 млн
-1,42 млн
-4,67 млн
-6,88 млн
Net profit margin
-131,70%
-33,62%
-148,85%
-321,58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-65,00 миң
-18,00 миң
-155,00 миң
-143,00 миң
Net interest expenses
-65,00 миң
-18,00 миң
-155,00 миң
-143,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,60 млн
-1,04 млн
-3,31 млн
-5,16 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer